Académique Documents
Professionnel Documents
Culture Documents
LIVER IN GENERAL
Susceptibility of the liver
This is an organ that is responsible for a lot of things you need to survive e.g. metabolising bile salts to help with fatty
diets, glucose metabolism, glycogen storage etc.
Location
Liver Anatomy
o There is a massive amount of blood/air space behind the endothelial cells i.e. Space of Disse (also in
the kidney because its also a detoxifying organ). This allows large molecules to gain access to the
hepatocytes. It also acts as a sieve so anything larger than 200 kilodalton (large protein) wont be able
to get through the fenestrate. But it allows plasma proteins and most of our drugs (antibodies i..e 150
kilodalton) to get to the hepatocytes which are on the edge and have villi projections to increase
surface area for absorption.
Liver Histology
30% of the blood volume will go through the liver via the
hepatic arterioles. So you get an accumulation of O2
depleted blood from the GIT and O2 rich blood from
arteriole.
Liver Physiology
Hepatocytes are combined into acini. Hepatic vein and artery filters through single cell layers of hepatic cells. The all
accumulates in the bile canaliculi to the bile duct. Kupffer cells are resident macrophages and they account for 80% of
macrophages in our body i.e. this is an area that is heavily monitored by the immune system. Kuppfer cells look for
particular molecules that have gotten into the GIT that got into the liver and shouldnt be there.
3 main acini zones
Zone 1 periportal
o Closest to portal vein
o Most important metabolic functions happen here
Fatty acid oxidation
Gluconeogenesis
Ammonia detoxification
o Most O2 rich area so we have the most mitochondrial in this zone
Zone 2 midzonal
Zone 3 centrolobular
o In the central vein, where it becomes almost hypoxic (deprived of O2), we see an increase in
cytochrome P450 i.e. phase 1 and 2 enzymes. If we did a staining of the liver to look for CYP450, we
find them located near the central vein they need low O2 levels to occur/work.
HEPATOTOXINS
Hepatic drug metabolism and transport
1. Drugs on sinusoidal blood lumen and most of them need to be actively transported via solute carriers
because it would take a long time if they were to use passive diffusion.
2. Once inside the cell, most lipophilic drugs require Phase I metabolism by CYP450.
3. Phase II metabolism occurs.
4. Molecules get actively transported by solute carriers or ABC transporters (which are ATP dependent) to the
bile canaliculi.
5. End up with polar metabolites that can be excreted into the small intestine and eventually excreted through
the faeces.
Note: ABC-B1 is looked at because it can easily be upregulated on the surface of the cell to allow for a 2nd round of
recirculation.
Sources
Food
o Contaminants e.g. myocotoxins, fungicides
o Mainly a problem in developing areas where they dont have good control of their fungus populations
on staple food.
Industrial exposure
o Solvents, CCI4, vinyl chloride, heavy metals
Drugs
o Paracetamol, chlorpromazine, anabolic steroids toxicity only happens if there is an OD or children
taking lots of tablets unnecessarily
o Most drugs dont cause hepatotoxicity
Classification
3. If liver damage isnt repaired via the livers amazing regeneration properties, there is chronic damage. FIB and CIRR
and severe side effects of liver damage.
ACUTE RESPONSES
Acute Response Info + MoA Example
Hepatitis Inflammation of the liver
Steatosis (fatty WHAT Ethanol significant cause
liver, liposis) Accumulation of lipids in hepatocytes (liver NASH obesity related disease
no longer brown colour, more yellow)
Mainly triglycerides
Very common response to changes in diet
Microvesicular or macrovesicular depending
on size of the droplets
Commonly accompanies necrosis i.e. once
the cell becomes so engulfed by lipid, it
cant function properly go on transplant
list b/c cant perform normal homeostatic
metabolism
Cholestasis WHAT Chlorpromazine
Blocked bile duct Cyclosporine
May occur with or without necrosis Oestrogens
Inhibition of bile salt secretion by blockade Phalloidin
of transporters on canalicular side
Functionally = decrease in bile flow
Morphologically = accumulation of bile in
hepatocytes (yellow bile deposits)
Clinically = rise in blood of bile excretory
products = jaundice
Can occur in absence of hepatitis i.e. even if
you have acute damage in liver, because its
not hepatocyte driven the cells wont open
up and release contents
Necrosis WHAT Panadol
Zonal: rarely due to parent drug itself Ecstasy
Diffuse: usually idiosyncratic where there is Phalloides
an immune reaction to drug and resembles Cocaine
viral hepatitis where the whole liver is Ferrous sulphate
affected not just one area Phosphorus
Background
Paracetamol OD can cause substantial toxic effects to the liver. ~8000 patients/year are treated in Australia and a lot
of them are children. Self-harm is usually impulsive and is not the same as deliberate suicide intent (cries for help).
In Australia, the median dose taken in an OD is 12g (one packet). Treatment for paracetamol overdose usually occurs
in hospitals when 10g (20 tablets) has been consumed. This pushed for non-pharmacy sites to put less tablets in their
packets to prevent OD cases (20 is max).
Case Study
27-year-old woman took an OD of 20 tablets. The follow day she was nauseated and vomited several times, but she
waited 48 hours before presenting to an ED. She had no other significant medical problems. She denied a history of
liver disease, alcohol abuse or risk factors for viral hepatitis.
At the hospital, she was oriented but drowsy and mildly jaundiced. After doing a blood test, it was found there was
elevated serum bilirubin and liver function enzymes (ALT, AST, ALP) which were in the 1000s and normally they are
<200. Paracetamol levels were also very high. Serum paracetamol adducts were also positive. Adducts are the protein
interactions that cause toxicity.
For treatment, she was admitted to the intensive care unit and given IV N-acetylcysteine which prevent protein-drug
adducts.
Bold: >2-3g
Phase 1 (CYP2E1)
Problem with CYP2E1 metabolism is that it forms a very toxic metabolite called NAPQI
NAPQI forms protein adducts in hepatocytes
It is toxic reactions with proteins and nucleic acids
Adducts are difficult for the cell to repair so the cells just go into apoptosis
Mechanism for preventing NAPQI formation:
o Rapidly add glutathione on the ends of NAPQI so it gets actively secreted into the bile
o Requires huge amounts of GSH so you deplete ~70% of hepatocyte GSH with this large dose of
paracetamol
o Problem if you took lots of alcohol because alcohol also requires lots of GSH to detoxify
o N-acetylcysteine is an alternative source of GSH i.e. breaks down into GSH and thats why we give it
at very high doses intravenously
Zone 3 Necrosis
Zone 1 Necrosis
Zone 1 necrosis is mainly due to heavy metal toxicity because this is where they are being predominantly passing
through Zone 1 first. But these molecules tend to not get metabolised so they just stay in hepatocytes and arent
transported. There is preferential uptake and high O2 levels in this zone.
Examples
LIVER CANCER
Risk factors for HCC
Trends
HCC rates vary with geographic location, ethnicity and gender. Incidence is higher in Asia (China, Indonesia) and parts
of Africa. It is lower in more developed nations such as the US, Canada and Australia.
Aflatoxins
RR of HCC = 3.4
Liver cancer incidence correlated with geographical contamination with aflatoxins in non-industrial
developing countries
Produced by Aspergillus spp.
4 common forms B1, B2, G1 and G2
Metabolite aflatoxin M1 is in animal products (milk)
HCC starts from contaminated staple foods e.g. corn, peanuts, rice
Acute symptoms
o GIT toxicity, liver damage
Chronic symptoms
o Jaundice, cirrhosis, liver cancer
Why are there so few cases?
o Additional factor is needed
o Mutations of p53 suppressor gene is required for cancer in humans and animals need this to make
mutations higher
o RR if Hep B antigen is positive is 59.4 = 20% of population (risk jumping 60 fold)
Metabolism of aflatoxin B1 in humans
Example Questions
A. Zone 1
B. Zone 2
C. Zone 3 (main site for metabolism in the liver)
Q2. What would happen if the patient was also a chronic alcoholic?
A. Increased toxicity
B. Decreased toxicity
C. Dont know
Ethanol induces CYP2E1 and increases the amount of drug metabolism to NAPQI. Alcohol also depletes glutathione
for its own metabolism.
Q3. What would happen if the patient was also taking phenytoin?
A. Increased toxicity
B. Decreased toxicity
C. Dont know
Phenytoin inhibits UGT enzymes, therefore reducing one of the main detoxification pathways and shunting
metabolism to alternate pathways (namely CYP2E1, SULFT1 pathway is saturated at high paracetamol doses, so can
not increase to compensate for UGT inhibition).